首页 | 本学科首页   官方微博 | 高级检索  
     


Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma
Authors:Ali Rihani MSc  Tom Van Maerken MD  PhD  Bram De Wilde MD  Fjoralba Zeka MSc  Geneviève Laureys MD  PhD  Koen Norga MD  PhD  Gian Paolo Tonini PhD  Simona Coco PhD  Rogier Versteeg PhD  Rosa Noguera MD  PhD  Johannes H. Schulte MD  PhD  Angelika Eggert MD  PhD  Raymond L. Stallings PhD  Frank Speleman PhD  Jo Vandesompele PhD
Affiliation:1. Center for Medical Genetics, Ghent University, , Ghent, Belgium;2. Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University Hospital, , Ghent, Belgium;3. Department of Pediatric Oncology, Antwerp University Hospital, , Edegem, Belgium;4. Neuroblastoma Laboratory, Onco/Hematology Laboratory, SDB Department, Pediatric Research Institute, University of Padua, , Padua, Italy;5. Lung Cancer Unit, IRCCS AOU San Martino—IST, , Genoa, Italy;6. Department of Human Genetics, Academic Medical Center, University of Amsterdam, , Amsterdam, The Netherlands;7. Department of Pathology, Medical School, University of Valencia, , Valencia, Spain;8. Department of Pediatric Oncology and Haematology, University Children's Hospital Essen, , Essen, Germany;9. National Children's Research Centre, Our Lady's Children's Hospital, , Crumlin, Dublin, Ireland;10. Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, , Dublin, Ireland
Abstract:
Keywords:genotyping  MDM2 SNP309  neuroblastoma  survival
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号